SCHEMBL13626406

SCHEMBL13626406

BN1C(=O)CC[C@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13948664 1.00 — —
SCHEMBL13626390 0.72 PTGER2 (0.32) —
SCHEMBL262126 0.72 — —
SCHEMBL13626381 0.72 — —
SCHEMBL2302701 0.72 — —
SCHEMBL23692529 0.70 — —
SCHEMBL15163727 0.70 — —
SCHEMBL18832370 0.70 — —
SCHEMBL15214691 0.70 — —
SCHEMBL8283271 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286787-A1 SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS ALLERGAN, INC. (US) 2009-11-19 — — US disclosed
US-20090036708-A1 Novel Process for the Preparation of Nonracemic Long Chain alpha-Amino Acid Derivatives WUXI PHARMATECH CO., LTD. (CN) 2009-02-05 — — US disclosed
Send feedback